OmniAsset
Get app

OmniAsset › Mutual funds › Baroda BNP Paribas Health and Wellness Fund

Baroda BNP Paribas Health and Wellness Fund

Sectoral / Thematic fund benchmarked to BSE Healthcare Total Return Index. Every figure below is read from one dated snapshot; what the snapshot cannot prove is left out, never estimated.

Latest NAV2 Sep 202610.975
CategorySectoral / Thematic
PlanDirect · Growth
Launched9 Jun 2025
Risk labelthe scheme's own riskometerVery high
Legal benchmarkSEBI Tier-1BSE Healthcare Total Return Index
Expense ratiodirect plan, a year1.51%
AUM₹10.8 Cr
Growth of ₹10,000₹10,9611 Jul 2025 to 2 Sep 2026
₹11,109₹10,605₹10,102₹9,598₹9,095Jul 2025Oct 2025Feb 2026May 2026Sep 2026
₹10,961 (+8.1% a year) Baroda BNP Paribas Health and Wellness Fund

Performance (trailing, annualised)

1Y annualised12.37%

Point-to-point from the fund's own published NAV; a period the history does not span is left out.

SIP returns

SIP 1Y (₹10,000 a month)invested ₹1,20,000 → worth ₹1,34,81523.57%

₹10,000 on the first of every month, valued at the latest NAV, as an annualised rate (XIRR).

Risk

Volatility (3Y)11.50%
Downside deviation (3Y)8.07%
Maximum drawdown-11.11%

Management

Fund managerMr. Rohan Korde, Mr. Ankeet Pandya
Managing since2 Sep 2026

What it holds

SecurityWeight
Sun Pharmaceutical Industries Ltd7.6%
Lupin Ltd6.6%
Laurus Labs Ltd6.3%
Ipca Laboratories Ltd5.8%
Torrent Pharmaceuticals Ltd5.4%
Divi's Laboratories Ltd5.3%
Apollo Hospitals Enterprise Ltd4.9%
JB Chemicals & Pharmaceuticals Ltd4.6%
Fortis Healthcare Ltd4.3%
Astrazeneca Pharma India Ltd3.9%
SectorWeight
Healthcare91.1%
Financial5.4%
Industrials1.5%

Portfolio disclosed: 98.0% by weight.

Related

Source: the OmniAsset signed reference snapshot, as of 3 Sep 2026. Figures are deterministic; missing data is withheld, never estimated. See methodology and data sources. Not investment advice.

Research this fund and compare it — on your device.

Get OmniAsset on Google Play The mutual fund tracker